418 related articles for article (PubMed ID: 34386436)
1. Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma.
Bughda R; Dimou P; D'Souza RR; Klampatsa A
Immunotargets Ther; 2021; 10():313-323. PubMed ID: 34386436
[TBL] [Abstract][Full Text] [Related]
2. Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy.
Das S; Valton J; Duchateau P; Poirot L
Front Immunol; 2023; 14():1172681. PubMed ID: 37251405
[TBL] [Abstract][Full Text] [Related]
3. Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy.
Shahvali S; Rahiman N; Jaafari MR; Arabi L
Drug Deliv Transl Res; 2023 Jul; 13(7):2041-2056. PubMed ID: 36840906
[TBL] [Abstract][Full Text] [Related]
4. FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer.
Liu Y; Sun Y; Wang P; Li S; Dong Y; Zhou M; Shi B; Jiang H; Sun R; Li Z
J Transl Med; 2023 Apr; 21(1):255. PubMed ID: 37046312
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
Kakarla S; Chow KK; Mata M; Shaffer DR; Song XT; Wu MF; Liu H; Wang LL; Rowley DR; Pfizenmaier K; Gottschalk S
Mol Ther; 2013 Aug; 21(8):1611-20. PubMed ID: 23732988
[TBL] [Abstract][Full Text] [Related]
6. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
7. Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors.
Li F; Zhao S; Wei C; Hu Y; Xu T; Xin X; Zhu T; Shang L; Ke S; Zhou J; Xu X; Gao Y; Zhao A; Gao J
Front Immunol; 2022; 13():958082. PubMed ID: 36479116
[TBL] [Abstract][Full Text] [Related]
8. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
9. Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control.
Zhen Z; Tang W; Wang M; Zhou S; Wang H; Wu Z; Hao Z; Li Z; Liu L; Xie J
Nano Lett; 2017 Feb; 17(2):862-869. PubMed ID: 28027646
[TBL] [Abstract][Full Text] [Related]
10. Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager.
de Sostoa J; Fajardo CA; Moreno R; Ramos MD; Farrera-Sal M; Alemany R
J Immunother Cancer; 2019 Jan; 7(1):19. PubMed ID: 30683154
[TBL] [Abstract][Full Text] [Related]
11. Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment.
Loureiro LR; Hoffmann L; Neuber C; Rupp L; Arndt C; Kegler A; Kubeil M; Hagemeyer CE; Stephan H; Schmitz M; Feldmann A; Bachmann M
J Exp Clin Cancer Res; 2023 Dec; 42(1):341. PubMed ID: 38102692
[TBL] [Abstract][Full Text] [Related]
12. The application of the fibroblast activation protein α-targeted immunotherapy strategy.
Jiang GM; Xu W; Du J; Zhang KS; Zhang QG; Wang XW; Liu ZG; Liu SQ; Xie WY; Liu HF; Liu JS; Wu BP
Oncotarget; 2016 May; 7(22):33472-82. PubMed ID: 26985769
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74.
Lee IK; Noguera-Ortega E; Xiao Z; Todd L; Scholler J; Song D; Liousia M; Lohith K; Xu K; Edwards KJ; Farwell MD; June CH; Albelda SM; Puré E; Sellmyer MA
Clin Cancer Res; 2022 Dec; 28(24):5330-5342. PubMed ID: 35972732
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review.
Xin L; Gao J; Zheng Z; Chen Y; Lv S; Zhao Z; Yu C; Yang X; Zhang R
Front Oncol; 2021; 11():648187. PubMed ID: 34490078
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
[TBL] [Abstract][Full Text] [Related]
16. Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.
Gunderson AJ; Yamazaki T; McCarty K; Phillips M; Alice A; Bambina S; Zebertavage L; Friedman D; Cottam B; Newell P; Gough MJ; Crittenden MR; Van der Veken P; Young KH
PLoS One; 2019; 14(2):e0211117. PubMed ID: 30726287
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer.
Henze J; Tacke F; Hardt O; Alves F; Al Rawashdeh W
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32481570
[TBL] [Abstract][Full Text] [Related]
18. New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress.
Imlimthan S; Moon ES; Rathke H; Afshar-Oromieh A; Rösch F; Rominger A; Gourni E
Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681246
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors.
Xiao Z; Todd L; Huang L; Noguera-Ortega E; Lu Z; Huang L; Kopp M; Li Y; Pattada N; Zhong W; Guo W; Scholler J; Liousia M; Assenmacher CA; June CH; Albelda SM; Puré E
Nat Commun; 2023 Aug; 14(1):5110. PubMed ID: 37607999
[TBL] [Abstract][Full Text] [Related]
20. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
Lee J; Fassnacht M; Nair S; Boczkowski D; Gilboa E
Cancer Res; 2005 Dec; 65(23):11156-63. PubMed ID: 16322266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
